Literature DB >> 18301898

Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population.

H J Lee1, G H Lee, S Nah, K H Lee, H Yang, Y M Kim, W Chun, S Hong, S Kim.   

Abstract

Due to an imbalance in the MMP:TIMP ratio determined a tissue damage in arthritis, it is hypothesized that polymorphic variations of the TIMP genes are associated with regulation of the MMP:TIMP balance. To test this hypothesis, the presence of single nucleotide polymorphisms (SNPs) located in the human TIMP-2 and TIMP-4 genes was confirmed in the Korean RA and OA patients. We performed a case-control study comprising 109 unrelated Korean OA patients, 177 unrelated Korean RA patients and 175 healthy subjects. There were statistically significant differences in the genotype distribution and allele frequencies of the C/T polymorphism of TIMP-4 gene between OA and control groups (P = 0.0002 and P = 0.001, respectively). However, no significant association between TIMP-2 polymorphisms and OA was observed. Also, no difference was observed when allele or genotype frequencies of both TIMP-2 and TIMP-4 gene polymorphisms were compared between RA and controls. We demonstrated that the C/T polymorphism which is located on the 3'-untranslational regions of the TIMP-4 gene might be associated with susceptibility to OA patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301898     DOI: 10.1007/s00296-008-0545-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis.

Authors:  Z Mustafa; K Chapman; C Irven; A J Carr; K Clipsham; J Chitnavis; J S Sinsheimer; V A Bloomfield; M McCartney; O Cox; B Sykes; J Loughlin
Journal:  Rheumatology (Oxford)       Date:  2000-03       Impact factor: 7.580

2.  Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).

Authors:  Y E Liu; M Wang; J Greene; J Su; S Ullrich; H Li; S Sheng; P Alexander; Q A Sang; Y E Shi
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

Review 3.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

Review 4.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

5.  Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery.

Authors:  Mahmut Y Celiker; Nungavaram Ramamurthy; Jin-Wen Xu; Mingsheng Wang; Yangfu Jiang; Robert Greenwald; Y Eric Shi
Journal:  Arthritis Rheum       Date:  2002-12

6.  Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis.

Authors:  J Loughlin; J S Sinsheimer; Z Mustafa; A J Carr; K Clipsham; V A Bloomfield; J Chitnavis; A Bailey; B Sykes; K Chapman
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

7.  Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.

Authors:  L C Tetlow; D J Adlam; D E Woolley
Journal:  Arthritis Rheum       Date:  2001-03

Review 8.  Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Authors:  D T Felson; R C Lawrence; P A Dieppe; R Hirsch; C G Helmick; J M Jordan; R S Kington; N E Lane; M C Nevitt; Y Zhang; M Sowers; T McAlindon; T D Spector; A R Poole; S Z Yanovski; G Ateshian; L Sharma; J A Buckwalter; K D Brandt; J F Fries
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnish women.

Authors:  Svetlana Solovieva; Ari Hirvonen; Päivi Siivola; Tapio Vehmas; Katariina Luoma; Hilkka Riihimäki; Päivi Leino-Arjas
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Expression profiling of metalloproteinases and their inhibitors in cartilage.

Authors:  Lara Kevorkian; David A Young; Clare Darrah; Simon T Donell; Lee Shepstone; Sarah Porter; Sarah M V Brockbank; Dylan R Edwards; Andrew E Parker; Ian M Clark
Journal:  Arthritis Rheum       Date:  2004-01
View more
  6 in total

1.  Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population.

Authors:  Ju Yeon Ban; Kyung Leem Yoon; Su Kang Kim; Sungwook Kang; Joo-Ho Chung
Journal:  Pediatr Cardiol       Date:  2008-12-02       Impact factor: 1.655

2.  Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes.

Authors:  Wensheng Huang; Mohammed El Mabrouk; Judith Sylvester; Faramaze Dehnade; Muhammad Zafarullah
Journal:  Open Rheumatol J       Date:  2011-11-29

3.  TIMP-2 SNPs rs7342880 and rs4789936 are linked to risk of knee osteoarthritis in the Chinese Han Population.

Authors:  Pengcheng Xu; Wen Guo; Tianbo Jin; Jihong Wang; Dongsheng Fan; Zengtao Hao; Shangfei Jing; ChaoQian Han; Jieli Du; Dong Jiang; Shuzheng Wen; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-01-03

Review 4.  Targeting Dysregulation of Metalloproteinase Activity in Osteoarthritis.

Authors:  Kazuhiro Yamamoto; David Wilkinson; George Bou-Gharios
Journal:  Calcif Tissue Int       Date:  2020-08-09       Impact factor: 4.333

Review 5.  Proteases involved in cartilage matrix degradation in osteoarthritis.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2011-07-08

Review 6.  Tissue inhibitor of metalloproteinases-4. The road less traveled.

Authors:  Jorge Melendez-Zajgla; Luis Del Pozo; Gisela Ceballos; Vilma Maldonado
Journal:  Mol Cancer       Date:  2008-11-21       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.